首页 > 最新文献

Journal of minimally invasive gynecology最新文献

英文 中文
Robot-Assisted Partial Cystectomy for Deep Infiltrating Endometriosis of the Bladder With the Hugo RAS System "利用Hugo RAS系统进行机器人辅助膀胱部分切除术治疗膀胱深部浸润性子宫内膜异位症"。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.jmig.2024.04.012
<div><h3>Objective</h3><p><span><span>Involvement of the lower urinary tract is found in 0.2 to 2.5% of all deep infiltrating </span>endometriosis (DIE) [</span><span><span>1</span></span>,<span><span>2</span></span><span>]. The bladder is the most affected organ with a prevalence of up to 80% of cases [</span><span><span>3</span></span><span>]. Patients with bladder endometriosis are often symptomatic (dysuria, hyperactive bladder, recurrent urinary tract infections, and hematuria). Surgery is the gold standard treatment for this condition when medical therapy fails [</span><span><span>1</span></span>,<span><span>2</span></span>]. Several studies have shown the feasibility, effectiveness, and safety of the laparoscopic approach [<span><span>4</span></span><span>] but data about robotic-assisted approach are missing in literature. Currently, novel platforms are entering the market and the Hugo™RAS (Medtronic, Minneapolis, USA) is a new system (HRS) consisting of an open console with 3D-HD screen and a multimodular bedside units. Even if some series are already available for radical cystectomies for oncologic purposes [</span><span><span>5</span></span>], a full description of DIE surgery performed with HRS is still lacking. Aim of this video-article is to show our technique and surgical setup to carry out a complex case of anterior compartment DIE.</p></div><div><h3>Design</h3><p>A step-by-step explanation of surgical technique with narrated video footage.</p></div><div><h3>Setting</h3><p>Tertiary Level Academic Hospital “IRCCS Azienda Ospedaliero—Universitaria di Bologna” Bologna, Italy.</p></div><div><h3>Intervention</h3><p><span><span><span>A 36-year-old nulliparous woman affected by DE was referred to our center due to severe </span>dyspareunia<span>, dysuria with </span></span>hematuria<span> and postvoiding pain not responsive to oral progestins<span><span>. The preoperative work up consisted of a gynecological examination, pelvic ultrasound and MRI that showed the presence of an endometriotic nodule of the </span>bladder base<span>. All possible therapeutic strategies and related complications have been discussed with the patient before the signature of the informed consent. To carry out the procedure a “straight” port placement in a “compact” docking configuration [</span></span></span></span><span><span>6</span></span><span>] was installed. After developing the paravesical spaces bilaterally, the bladder nodule was approached in a latero-medial direction then a partial cystectomy with macroscopical free margins was performed. A double layer horizontal running suture<span> with barbed thread was used to repair the bladder wall.</span></span></p></div><div><h3>Conclusion</h3><p>To the best of our knowledge, this is the first case of bladder endometriotic nodule excision performed with HRS. We explained our technique and robotic set-up to successfully manage a compelx case of DIE of the bladder.</p></div><div><h3>Video Abstract</h3><p><span
目的在所有深部浸润性子宫内膜异位症(DIE)中,有0.2%至2.5%的病例会累及下尿路[1,2]。膀胱是受影响最大的器官,发病率高达 80% [3]。膀胱子宫内膜异位症患者通常有症状(排尿困难、膀胱活动过度、反复尿路感染和血尿)。当药物治疗无效时,手术是治疗这种疾病的金标准[1,2]。多项研究表明,腹腔镜方法具有可行性、有效性和安全性[4],但文献中缺少有关机器人辅助方法的数据。目前,新型平台正在进入市场,Hugo™RAS(美敦力,美国明尼阿波利斯)是一种新型系统(HRS),由带有 3D 高清屏幕的开放式控制台和多模块床旁装置组成。尽管目前已有一些肿瘤根治性膀胱切除术的案例[5],但仍缺乏使用 HRS 进行 DIE 手术的完整描述。本视频文章旨在展示我们在进行一例复杂的前室DIE手术时所采用的技术和手术设置。背景意大利博洛尼亚的 "IRCCS Azienda Ospedaliero-Universitaria di Bologna "三级学术医院。干预一位36岁的无子宫女性因严重的排尿困难、排尿困难伴血尿以及口服孕激素无效的排尿后疼痛而被转诊至本中心。术前检查包括妇科检查、盆腔超声和核磁共振成像,结果显示膀胱底部存在子宫内膜异位结节。在签署知情同意书之前,已与患者讨论了所有可能的治疗策略和相关并发症。手术采用 "紧凑 "对接配置[6]的 "直 "端口置入。在开拓双侧膀胱旁间隙后,从侧内侧方向接近膀胱结节,然后进行膀胱部分切除术,并在大体上游离膀胱边缘。结论 据我们所知,这是首例使用 HRS 进行的膀胱子宫内膜异位结节切除术。我们介绍了成功处理一例膀胱 DIE 的技术和机器人设置。视频摘要下载:下载视频 (142MB)
{"title":"Robot-Assisted Partial Cystectomy for Deep Infiltrating Endometriosis of the Bladder With the Hugo RAS System","authors":"","doi":"10.1016/j.jmig.2024.04.012","DOIUrl":"10.1016/j.jmig.2024.04.012","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;p&gt;&lt;span&gt;&lt;span&gt;Involvement of the lower urinary tract is found in 0.2 to 2.5% of all deep infiltrating &lt;/span&gt;endometriosis (DIE) [&lt;/span&gt;&lt;span&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;,&lt;span&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;&lt;span&gt;]. The bladder is the most affected organ with a prevalence of up to 80% of cases [&lt;/span&gt;&lt;span&gt;&lt;span&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span&gt;]. Patients with bladder endometriosis are often symptomatic (dysuria, hyperactive bladder, recurrent urinary tract infections, and hematuria). Surgery is the gold standard treatment for this condition when medical therapy fails [&lt;/span&gt;&lt;span&gt;&lt;span&gt;1&lt;/span&gt;&lt;/span&gt;,&lt;span&gt;&lt;span&gt;2&lt;/span&gt;&lt;/span&gt;]. Several studies have shown the feasibility, effectiveness, and safety of the laparoscopic approach [&lt;span&gt;&lt;span&gt;4&lt;/span&gt;&lt;/span&gt;&lt;span&gt;] but data about robotic-assisted approach are missing in literature. Currently, novel platforms are entering the market and the Hugo™RAS (Medtronic, Minneapolis, USA) is a new system (HRS) consisting of an open console with 3D-HD screen and a multimodular bedside units. Even if some series are already available for radical cystectomies for oncologic purposes [&lt;/span&gt;&lt;span&gt;&lt;span&gt;5&lt;/span&gt;&lt;/span&gt;], a full description of DIE surgery performed with HRS is still lacking. Aim of this video-article is to show our technique and surgical setup to carry out a complex case of anterior compartment DIE.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Design&lt;/h3&gt;&lt;p&gt;A step-by-step explanation of surgical technique with narrated video footage.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Setting&lt;/h3&gt;&lt;p&gt;Tertiary Level Academic Hospital “IRCCS Azienda Ospedaliero—Universitaria di Bologna” Bologna, Italy.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Intervention&lt;/h3&gt;&lt;p&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;A 36-year-old nulliparous woman affected by DE was referred to our center due to severe &lt;/span&gt;dyspareunia&lt;span&gt;, dysuria with &lt;/span&gt;&lt;/span&gt;hematuria&lt;span&gt; and postvoiding pain not responsive to oral progestins&lt;span&gt;&lt;span&gt;. The preoperative work up consisted of a gynecological examination, pelvic ultrasound and MRI that showed the presence of an endometriotic nodule of the &lt;/span&gt;bladder base&lt;span&gt;. All possible therapeutic strategies and related complications have been discussed with the patient before the signature of the informed consent. To carry out the procedure a “straight” port placement in a “compact” docking configuration [&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span&gt;&lt;span&gt;6&lt;/span&gt;&lt;/span&gt;&lt;span&gt;] was installed. After developing the paravesical spaces bilaterally, the bladder nodule was approached in a latero-medial direction then a partial cystectomy with macroscopical free margins was performed. A double layer horizontal running suture&lt;span&gt; with barbed thread was used to repair the bladder wall.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;p&gt;To the best of our knowledge, this is the first case of bladder endometriotic nodule excision performed with HRS. We explained our technique and robotic set-up to successfully manage a compelx case of DIE of the bladder.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Video Abstract&lt;/h3&gt;&lt;p&gt;&lt;span","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140761385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regarding “Vaginal Cuff Dehiscence in Transgender Patients After Minimally Invasive Hysterectomy” 关于 "微创子宫切除术后变性患者的阴道袖带开裂"。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.jmig.2024.04.028
{"title":"Regarding “Vaginal Cuff Dehiscence in Transgender Patients After Minimally Invasive Hysterectomy”","authors":"","doi":"10.1016/j.jmig.2024.04.028","DOIUrl":"10.1016/j.jmig.2024.04.028","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141199702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regarding “Is Intravenous Dextrose Infusion During Emergence From Anesthesia Effective in Improving the PONV in Gynecologic Laparoscopy? A Randomized Controlled Trial” 关于 "麻醉清醒时静脉输注葡萄糖对改善妇科腹腔镜手术中的 PONV 有效吗?随机对照试验"。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.jmig.2024.04.027
{"title":"Regarding “Is Intravenous Dextrose Infusion During Emergence From Anesthesia Effective in Improving the PONV in Gynecologic Laparoscopy? A Randomized Controlled Trial”","authors":"","doi":"10.1016/j.jmig.2024.04.027","DOIUrl":"10.1016/j.jmig.2024.04.027","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141081474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Preoperative Bilateral Ultrasound-Guided Quadratus Lumborum Nerve Block on Quality of Recovery After Minimally Invasive Hysterectomy in an Enhanced Recovery After Surgery (ERAS) Setting 术前超声引导下双侧腰四神经阻滞对微创子宫切除术后恢复质量的影响(ERAS)。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.jmig.2024.05.019

Study Objective

To assess the effect of preoperative bilateral ultrasound-guided quadratus lumborum nerve block (QLB) on quality of recovery after minimally invasive hysterectomy, in an enhanced recovery after surgery setting.

Design

Randomized, controlled, double-blinded trial (Canadian Task Force level I).

Setting

University-affiliated tertiary medical center.

Patients

All women undergoing an elective robotic or laparoscopic hysterectomy. Women with chronic pain, chronic anticoagulation, and body mass index >50 kg/m2 were excluded.

Intervention

Patients were randomized with a 1:1 allocation, to one of the following 2 arms, and stratified based on robotic versus laparoscopic approach.

 1. QLB: QLB (bupivacaine) + sham local trocar sites infiltration (normal saline)

 2. Local infiltration: sham QLB (normal saline) + local infiltration (bupivacaine)

Measurements and Main Results

The primary outcome was defined as the quality of recovery score based on the validated questionnaire Quality of Recovery, completed 24 hours postoperatively. Secondary outcomes included dynamic pain scores, accumulated opioid consumption up to 24 hours, postoperative nausea and vomiting, surgical complications, length of hospital stay, time to first pain medication administration in the postanesthesia care unit, and adverse events. A total of 76 women were included in the study. Demographic characteristics were similar in both groups. Median age was 44 years (interquartile range 39–50), 47% of the participants were African American, and mean body mass index was 32.8 kg/m2 (standard deviation [SD] 8.1). The mean Quality of Recovery score was 179.1 (SD ± 10.3) in the QLB and 175.6 (SD ± 9.7) for the local anesthesia group (p = .072). All secondary outcomes were comparable between groups.

Conclusions

QLBs do not significantly improve quality of recovery after elective robotic or laparoscopic hysterectomy compared with local anesthetic port site infiltration.

研究目的评估术前双侧超声引导下腰股沟神经阻滞(QLB)对微创子宫切除术后恢复质量的影响:随机、对照、双盲试验(加拿大工作组 I 级):患者: 所有接受选择性机器人手术的女性:所有接受机器人或腹腔镜子宫切除术的女性。排除慢性疼痛、长期抗凝和体重指数(BMI)大于 50 kg/m2 的女性:患者按 1:1 随机分配到以下两组中的一组,并根据机器人与腹腔镜方法进行分层。1.QLB:QLB(布比卡因)+ Sham 局部套管部位浸润(生理盐水)。2.局部浸润:测量和主要结果:主要结果是根据术后 24 小时完成的有效问卷(QOR-40)得出的恢复质量评分。次要结果包括:动态疼痛评分、24 小时内阿片类药物累计用量、术后恶心和呕吐、手术并发症、住院时间、麻醉后护理病房(PACU)首次使用止痛药物的时间以及不良事件。研究共纳入了 76 名妇女。两组的人口统计学特征相似。中位年龄为 44(IQR 39-50)岁,47% 的参与者为非洲裔美国人,平均体重指数为 32.8(SD 8.1)kg/m2。QLB组的平均QOR-40评分为179.1(+/- 10.3SD),局麻组为175.6(+/- 9.7SD)(P=0.072)。各组的所有次要结果均具有可比性:结论:与局部麻醉端口部位浸润相比,QLB并不能明显改善择期机器人或腹腔镜子宫切除术后的恢复质量。
{"title":"Effect of Preoperative Bilateral Ultrasound-Guided Quadratus Lumborum Nerve Block on Quality of Recovery After Minimally Invasive Hysterectomy in an Enhanced Recovery After Surgery (ERAS) Setting","authors":"","doi":"10.1016/j.jmig.2024.05.019","DOIUrl":"10.1016/j.jmig.2024.05.019","url":null,"abstract":"<div><h3>Study Objective</h3><p><span>To assess the effect of preoperative bilateral ultrasound-guided quadratus lumborum nerve block (QLB) on quality of recovery after minimally invasive hysterectomy, in an </span>enhanced recovery after surgery setting.</p></div><div><h3>Design</h3><p>Randomized, controlled, double-blinded trial (Canadian Task Force level I).</p></div><div><h3>Setting</h3><p>University-affiliated tertiary medical center.</p></div><div><h3>Patients</h3><p><span><span>All women undergoing an elective robotic or laparoscopic hysterectomy. Women with chronic pain, chronic anticoagulation, and </span>body mass index &gt;50 kg/m</span><sup>2</sup> were excluded.</p></div><div><h3>Intervention</h3><p>Patients were randomized with a 1:1 allocation, to one of the following 2 arms, and stratified based on robotic versus laparoscopic approach.</p><p> <!-->1. QLB: QLB (bupivacaine) + sham local trocar sites infiltration (normal saline)</p><p> <!-->2. Local infiltration: sham QLB (normal saline) + local infiltration (bupivacaine)</p></div><div><h3>Measurements and Main Results</h3><p><span><span><span>The primary outcome was defined as the quality of recovery score based on the validated questionnaire Quality of Recovery, completed 24 hours postoperatively. Secondary outcomes included dynamic pain scores, accumulated opioid consumption up to 24 hours, postoperative nausea and vomiting, </span>surgical complications, length of hospital stay, time to first pain medication administration in the </span>postanesthesia care unit, and adverse events. A total of 76 women were included in the study. Demographic characteristics were similar in both groups. Median age was 44 years (interquartile range 39–50), 47% of the participants were African American, and mean body mass index was 32.8 kg/m</span><sup>2</sup><span> (standard deviation [SD] 8.1). The mean Quality of Recovery score was 179.1 (SD ± 10.3) in the QLB and 175.6 (SD ± 9.7) for the local anesthesia group (p = .072). All secondary outcomes were comparable between groups.</span></p></div><div><h3>Conclusions</h3><p>QLBs do not significantly improve quality of recovery after elective robotic or laparoscopic hysterectomy compared with local anesthetic port site infiltration.</p></div>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141155263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Operative Time and Accrual of Postoperative Complications in Minimally Invasive Versus Open Myomectomy 微创与开腹子宫肌瘤切除术的手术时间和术后并发症发生率。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.jmig.2024.05.010

Study Objective

To compare the prevalence and accrual of 30-day postoperative complications by operative time for open myomectomy (OM) and minimally invasive myomectomy (MIM).

Design

Retrospective cohort study

Setting

Hospitals participating in the National Surgical Quality Improvement Program database from January 2015 to December 2021.

Patients

Female patients aged ≥18 years undergoing OM or MIM.

Interventions

Patients were categorized into OM and MIM cohorts. Covariates associated with operative time and composite complications were identified using general linear model and chi-square or Fisher's exact test as appropriate. Adjusted spline regression was performed as a test of linearity between operative time and composite complications. Adjusted risk ratios of 30-day postoperative individual, minor, major, and composite complications by 60-minute operative time increments were estimated using Poisson regression with robust error variance.

Measurements and Main Results

Of 27 728 patients, 11 071 underwent MIM and 16 657 underwent OM. Mean operative times (SD) were 164.6 (82.0) for MIM and 129.2 (67.0) for OM. Raw composite complication rates were 5.5% for MIM and 15.8% for OM. Adjusted spline regression demonstrated linearity between operative time and relative risk of composite postoperative complications for both MIM and OM. MIM had higher adjusted relative risk (aRR, 95% CI) compared to OM of blood transfusion (1.55, 1.45–1.64 versus 1.29, 1.25–1.34), overall minor complications (1.13, 1.03–1.23 versus 1.01, 0.92–1.10), and overall major complications (1.43, 1.35–1.51 versus 1.27, 1.12–1.32). Operative time had greater impact on risk of composite complications for MIM than OM, reaching aRR 2.0 at 296 minutes versus 461 minutes for OM.

Conclusion

OM has a higher overall rate of composite, minor, and major complications compared to MIM. While operative time is independently and linearly associated with postoperative complications with myomectomy regardless of approach, optimizing surgical efficiency for MIM may be more critical than for OM.

研究目的比较开放式子宫肌瘤剔除术(OM)和微创子宫肌瘤剔除术(MIM)术后 30 天并发症的发生率和发生时间:设计:回顾性队列研究:2015年1月至2021年12月期间参与国家手术质量改进计划数据库的医院:年龄≥18岁、接受OM或MIM手术的女性患者:将患者分为OM和MIM队列。酌情使用一般线性模型和卡方检验或费雪精确检验确定与手术时间和综合并发症相关的协变量。对手术时间和综合并发症之间的线性关系进行了调整后的样条线回归检验。使用带有稳健误差方差的泊松回归估算了术后30天内单个并发症、轻微并发症、主要并发症和综合并发症在60分钟手术时间增量上的调整风险比:在 27,728 名患者中,11,071 人接受了 MIM,16,657 人接受了 OM。MIM和OM的平均手术时间(标清)分别为164.6(82.0)和129.2(67.0)。MIM和OM的原始复合并发症发生率分别为5.5%和15.8%。调整后的样条回归显示,MIM 和 OM 的手术时间与术后综合并发症相对风险之间呈线性关系。在输血(1.55,1.45-1.64 对 1.29,1.25-1.34)、总体轻微并发症(1.13,1.03-1.23 对 1.01,0.92-1.10)和总体主要并发症(1.43,1.35-1.51 对 1.27,1.12-1.32)方面,MIM 的调整相对风险(aRR,95% CI)高于 OM。手术时间对 MIM 综合并发症风险的影响大于 OM,MIM 在 296 分钟时达到 aRR 2.0,而 OM 为 461 分钟:结论:与 MIM 相比,OM 的综合并发症、轻微并发症和主要并发症总发生率更高。虽然无论采用哪种方法,手术时间都与子宫肌瘤剔除术的术后并发症呈线性相关,但优化 MIM 的手术效率可能比 OM 更为关键。
{"title":"Operative Time and Accrual of Postoperative Complications in Minimally Invasive Versus Open Myomectomy","authors":"","doi":"10.1016/j.jmig.2024.05.010","DOIUrl":"10.1016/j.jmig.2024.05.010","url":null,"abstract":"<div><h3>Study Objective</h3><p>To compare the prevalence and accrual of 30-day postoperative complications<span> by operative time for open myomectomy (OM) and minimally invasive myomectomy (MIM).</span></p></div><div><h3>Design</h3><p>Retrospective cohort study</p></div><div><h3>Setting</h3><p>Hospitals participating in the National Surgical Quality Improvement Program database from January 2015 to December 2021.</p></div><div><h3>Patients</h3><p>Female patients aged ≥18 years undergoing OM or MIM.</p></div><div><h3>Interventions</h3><p>Patients were categorized into OM and MIM cohorts. Covariates associated with operative time and composite complications were identified using general linear model and chi-square or Fisher's exact test as appropriate. Adjusted spline regression was performed as a test of linearity between operative time and composite complications. Adjusted risk ratios of 30-day postoperative individual, minor, major, and composite complications by 60-minute operative time increments were estimated using Poisson regression with robust error variance.</p></div><div><h3>Measurements and Main Results</h3><p>Of 27 728 patients, 11 071 underwent MIM and 16 657 underwent OM. Mean operative times (SD) were 164.6 (82.0) for MIM and 129.2 (67.0) for OM. Raw composite complication rates were 5.5% for MIM and 15.8% for OM. Adjusted spline regression demonstrated linearity between operative time and relative risk of composite postoperative complications for both MIM and OM. MIM had higher adjusted relative risk (aRR, 95% CI) compared to OM of blood transfusion (1.55, 1.45–1.64 versus 1.29, 1.25–1.34), overall minor complications (1.13, 1.03–1.23 versus 1.01, 0.92–1.10), and overall major complications (1.43, 1.35–1.51 versus 1.27, 1.12–1.32). Operative time had greater impact on risk of composite complications for MIM than OM, reaching aRR 2.0 at 296 minutes versus 461 minutes for OM.</p></div><div><h3>Conclusion</h3><p>OM has a higher overall rate of composite, minor, and major complications compared to MIM. While operative time is independently and linearly associated with postoperative complications with myomectomy regardless of approach, optimizing surgical efficiency for MIM may be more critical than for OM.</p></div>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140916800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors' Reply 作者回复。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.jmig.2024.05.018
{"title":"Authors' Reply","authors":"","doi":"10.1016/j.jmig.2024.05.018","DOIUrl":"10.1016/j.jmig.2024.05.018","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141081470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cervical Septum Incision Adversely Impacts Clinical Outcomes in Women With Complete Uterine Septum and Duplicated Cervix 子宫颈隔切开术对患有完全性子宫颈隔和重复子宫颈的妇女的临床效果有不利影响。
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.jmig.2024.05.012

Study Objective

To investigate the reproductive outcomes of women with complete septate uterus and duplicated cervix who either did or did not receive cervical septum incision during hysteroscopic transcervical incision of the uterine septum.

Design

Retrospective study approved by the hospital ethics committee.

Setting

Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.

Patients

Women with complete septate uterus and duplicated cervix who underwent hysteroscopic transcervical incision of the uterine septum in Obstetrics and Gynecology Hospital of Fudan University between January 2008 and December 2020 (n = 105).

Interventions

Hysteroscopic incision of the septum.

Measurements and Main Results

Included patients were grouped according to whether or not cervical septum incision was performed. Reproductive outcomes including gravidity, abortion rate, preterm birth rate, full-term birth rate, premature rupture of membranes, and cervical incompetence were assessed. In the no incision group, the abortion rate (7.4%) was significantly lower than that of the incision group (27.6%, p = .01); the preterm birth rate (4.6%) was significantly lower than that of the incision group (36.8%); and the full-term birth rate (95.5%) exceeded that of the incision group (63.2%, p <.01). Incidence of premature rupture of membranes and cervical incompetence during pregnancy was higher in the incision group (15.8% and 10.5%, p <.01 and p = .03).

Conclusion

Significantly improved reproductive outcomes were observed among patients with complete septate uterus and duplicated cervix whose cervical septum was preserved during the hysteroscopic transcervical incision of the uterine septum procedure.

研究目的调查在宫腔镜下经宫颈切开子宫纵隔时接受或未接受宫颈纵隔切开术的完全性子宫纵隔和重复宫颈妇女的生殖结局:经医院伦理委员会批准的回顾性研究:背景:中国上海复旦大学附属妇产科医院:患者:2008年1月至2020年12月期间,在复旦大学附属妇产科医院接受宫腔镜下经宫颈切开子宫纵隔手术的完全性子宫纵隔合并重复宫颈的妇女(n=105):干预措施:宫腔镜下子宫纵隔切开术:根据是否进行宫颈隔切开术对纳入的患者进行分组。对包括孕酮、流产率、早产率、足月分娩率、胎膜早破(PROM)和宫颈机能不全在内的生殖结果进行了评估。在无切口组中,流产率(7.4%)明显低于切口组(27.6%,P=0.01);早产率(4.6%)明显低于切口组(36.8%);足月分娩率(95.5%)超过切口组(63.2%,P=0.01):在宫腔镜下经宫颈切开子宫中隔术中保留宫颈中隔的完全性子宫中隔和重复宫颈患者的生育预后明显改善。
{"title":"Cervical Septum Incision Adversely Impacts Clinical Outcomes in Women With Complete Uterine Septum and Duplicated Cervix","authors":"","doi":"10.1016/j.jmig.2024.05.012","DOIUrl":"10.1016/j.jmig.2024.05.012","url":null,"abstract":"<div><h3>Study Objective</h3><p><span>To investigate the reproductive outcomes of women with complete septate uterus and duplicated cervix who either did or did not receive cervical septum </span>incision during hysteroscopic transcervical incision of the uterine septum.</p></div><div><h3>Design</h3><p>Retrospective study approved by the hospital ethics committee.</p></div><div><h3>Setting</h3><p>Obstetrics<span> and Gynecology Hospital of Fudan University, Shanghai, China.</span></p></div><div><h3>Patients</h3><p>Women with complete septate uterus and duplicated cervix who underwent hysteroscopic transcervical incision of the uterine septum in Obstetrics and Gynecology Hospital of Fudan University between January 2008 and December 2020 (n = 105).</p></div><div><h3>Interventions</h3><p>Hysteroscopic incision of the septum.</p></div><div><h3>Measurements and Main Results</h3><p><span>Included patients were grouped according to whether or not cervical septum incision was performed. Reproductive outcomes including gravidity, abortion rate, preterm birth rate, full-term birth rate, </span>premature rupture of membranes<span>, and cervical incompetence were assessed. In the no incision group, the abortion rate (7.4%) was significantly lower than that of the incision group (27.6%, p = .01); the preterm birth rate (4.6%) was significantly lower than that of the incision group (36.8%); and the full-term birth rate (95.5%) exceeded that of the incision group (63.2%, p &lt;.01). Incidence of premature rupture of membranes and cervical incompetence during pregnancy was higher in the incision group (15.8% and 10.5%, p &lt;.01 and p = .03).</span></p></div><div><h3>Conclusion</h3><p>Significantly improved reproductive outcomes were observed among patients with complete septate uterus and duplicated cervix whose cervical septum was preserved during the hysteroscopic transcervical incision of the uterine septum procedure.</p></div>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140916753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
International Societies 国际社团
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-01 DOI: 10.1016/S1553-4650(24)00329-7
{"title":"International Societies","authors":"","doi":"10.1016/S1553-4650(24)00329-7","DOIUrl":"10.1016/S1553-4650(24)00329-7","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142135897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
JMIG reviewer Spotlight – Dr Siddhi Mathur JMIG 评审员聚焦 - Siddhi Mathur 博士
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.jmig.2024.07.008
{"title":"JMIG reviewer Spotlight – Dr Siddhi Mathur","authors":"","doi":"10.1016/j.jmig.2024.07.008","DOIUrl":"10.1016/j.jmig.2024.07.008","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142136765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TOC 技术选择委员会
IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-01 DOI: 10.1016/S1553-4650(24)00331-5
{"title":"TOC","authors":"","doi":"10.1016/S1553-4650(24)00331-5","DOIUrl":"10.1016/S1553-4650(24)00331-5","url":null,"abstract":"","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1553465024003315/pdfft?md5=8ecf98c7caba4b2850452f54b5f7fa3c&pid=1-s2.0-S1553465024003315-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142135899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of minimally invasive gynecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1